Researchers from Vanderbilt University, TN; Kaiser Permanente, California; and other centers conducted a retrospective cohort study of serious cardiovascular events in 1,200,438 children and young adults, ages 2 to 24 years (mean 11.1 years), with ADHD
OBJECTIVE: This study examines the effect of ADHD diagnosis and stimulant medication for ADHD treatm...
Objective: To examine the naturalistic response to and cardiovascular side effects of stimulant medi...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobiological disorder exhibited by d...
CONTEXT: More than 1.5 million US adults use stimulants and other medications labeled for treatment ...
Accumulating evidence suggests a higher risk for cardiovascular diseases among individuals with ment...
Compared to children, adults with ADHD are at greater risk for developing adverse cardiovascular rel...
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder that is often t...
Although the prevalence of attention-deficit/hyperactivity disorder (ADHD) has been stable over the ...
Background It is well-known that childhood attention-deficit hyperactivity disorder (ADHD) is assoc...
The risk for adverse cardiac events in subjects between 3 and 20 years of age treated with methylphe...
Objective: This study examines the effect of ADHD (attention deficit hyperactivity disorder) diagnos...
BACKGROUND: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
BACKGROUND: Psychostimulants and atomoxetine have been shown to increase blood pressure, heart rate,...
Background: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
OBJECTIVE: This study examines the effect of ADHD diagnosis and stimulant medication for ADHD treatm...
Objective: To examine the naturalistic response to and cardiovascular side effects of stimulant medi...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobiological disorder exhibited by d...
CONTEXT: More than 1.5 million US adults use stimulants and other medications labeled for treatment ...
Accumulating evidence suggests a higher risk for cardiovascular diseases among individuals with ment...
Compared to children, adults with ADHD are at greater risk for developing adverse cardiovascular rel...
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder that is often t...
Although the prevalence of attention-deficit/hyperactivity disorder (ADHD) has been stable over the ...
Background It is well-known that childhood attention-deficit hyperactivity disorder (ADHD) is assoc...
The risk for adverse cardiac events in subjects between 3 and 20 years of age treated with methylphe...
Objective: This study examines the effect of ADHD (attention deficit hyperactivity disorder) diagnos...
BACKGROUND: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
BACKGROUND: Psychostimulants and atomoxetine have been shown to increase blood pressure, heart rate,...
Background: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
OBJECTIVE: This study examines the effect of ADHD diagnosis and stimulant medication for ADHD treatm...
Objective: To examine the naturalistic response to and cardiovascular side effects of stimulant medi...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
DOI
Add to ORKG